期刊文献+

HPLC测定复方头孢羟氨苄胶囊中的头孢羟氨苄和甲氧苄啶含量 被引量:1

HPLC ASSAY OF CEFADROXIL AND TRIMETHOPRIM IN COMPOUND CEFADROXIL CAPSULES
下载PDF
导出
摘要 目的:建立高效液相色谱法,同谱测定复方头孢羟氨苄胶囊中的头孢羟氨苄和甲氧苄啶含量。方法:用C_(18)柱,以pH3.5醋酸钠缓冲液—甲醇(77:23)为流动相,检测波长271nm。结果:头孢羟氨苄和甲氧苄啶进样量分别在3.2~4.8μg和0.64~0.96μg范围内,与相应主峰面积线性关系良好(γ分别为O.9996和O.9997),头孢羟氨苄和甲氧苄啶的平均回收率分别为99.9%和100.3%。结论:方法专属性强,简便快速,结果准确。 Objective: To establish a HPLC method for the assay of cefadroxil and trimethoprim inCompound Cefadroxil Capsules. Method: The chromatographic conditions were C_(18)column, pH3.5 sodiumacetate buffer-methanol (77:23) as mobile phase, and 271nm as detecting wavelength. Result: Both thestandard curves of cefadroxil and trimethoprim were rectilinear within the injecting quantity ranges of 3.2~4.8μg and 0.64~0.96μg respectively (γ were 0.9996 and 0.9997 respectively). The average recoveries of cefadroxil and trimethoprim were 99.9% and 100.3%. Conclusion: The method was specific,simple,andaccurate.
出处 《中国药品标准》 CAS 2002年第6期52-54,共3页 Drug Standards of China
关键词 复方头孢羟氨苄胶囊 高效液相色谱法 头孢羟氨苄 甲氧苄啶 含量测定 HPLC cefadroxil, trimethoprim compound capsules
  • 相关文献

同被引文献24

  • 1谢立新,金玉怀,张永红,殷长甫,张卫东,金世香,王志良,冷健,刘书睿.头孢羟氨苄与甲氧苄啶联合对葡萄球菌和乙型链球菌的体外抗菌作用[J].中国抗生素杂志,2005,30(4):229-232. 被引量:6
  • 2张菁,曹忆堇,张婴元.头孢羟氨苄的临床药物动力学研究[J].中国抗生素杂志,1995,20(1):45-47. 被引量:10
  • 3Lai CC,Wang CY, Chu CC, et al.Correlation between antimicrobial consumption and resistance among Staphy- lococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009 [J]. Eur J Clin Microbiol Infect Dis,doI 10. 1007/s 10096-010-1081-1.
  • 4Lee YT, Tsao SM, Lin HC, et al.Decline in the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) correlates with deceased antimicrobial consumption at a tertiary care hospital in Taiwan, 2001-2009 [J]. Int J Antimicrob Agents,2010,36 (6): 523-530.
  • 5Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil[J].Eur J Pharm Biophann, 2008,69 (2) : 658-666.
  • 6Kim JE, Kim SR, Lee SH, et al. The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix [ J ]. Int J Pharm, 2000,201 ( 1 ) : 29-36.
  • 7Como-Sabetti KJ, Harriman KH, Fridkin SK,et al.Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls [J]. Epidemiol Infect,2010, 1 (6):1-11.
  • 8Rachel J,Gordon, Franklin D, et al. Pathogenesis of methicillin-resistant staphylococcus aureus infection[J]. Clin Infect Dis, 2008,16 (7) : S350-S359.
  • 9Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant staphylococcus aureus at hospital admission and nosocomial infection in surgical patients[J]. JAMA,2008,299(10) : 1149-1157.
  • 10Loffler B, Hussain M, Grundmeier M, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils [J]. PLoS Pathog, 2010,6(1 ) :e100075.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部